Topoisomerase inhibitor, Gatifloxacin, Purity ≥98%

Cat. No.: X24-08-YM016

Topoisomerase inhibitor, Gatifloxacin, Purity ≥98%

Synonym: 112811-59-3; AM 1155; 1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid

  • MDL: MFCD00895399
  • CAS Number: 112811-59-3
  • Compound CID: 5379
Product Size
100 mg; 200 mg; 500 mg; 1000 mg
Price
Datasheet
MSDS
Properties
Description
Gatifloxacin, soluble in DMSO and insoluble in water and ethanol, is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting topoisomerase.
Molecular Weight
375.39
Molecular Formula
C19H22FN3O4
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 7 mg/mL (18.64 mM); Water: insoluble; Ethanol: insoluble
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Gatifloxacin is a DNA damage inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of infections that may occur in cancer patients.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.